Provided by Tiger Fintech (Singapore) Pte. Ltd.

SSY GROUP

3.090
+0.1304.39%
Volume:12.19M
Turnover:37.25M
Market Cap:9.07B
PE:8.63
High:3.090
Open:2.960
Low:2.960
Close:2.960
52wk High:4.520
52wk Low:2.580
Shares:2.94B
HK Float Shares:2.94B
Volume Ratio:4.44
T/O Rate:0.42%
Dividend:0.15
Dividend Rate:4.69%
EPS(LYR):0.358
ROE:8.81%
ROA:4.36%
PB:1.25
PE(LYR):8.63
PS:1.98

Loading ...

SSY Group Gets China Approvals for Three Drug Products

MT Newswires Live
·
Sep 01

SSY Group Ltd. Receives Regulatory Approval from China's NMPA for Allopurinol Tablets Production

Reuters
·
Sep 01

SSY Group Ltd - Obtains Nmpa Approval for Production, Registration for Allopurinol Tablets

THOMSON REUTERS
·
Sep 01

BRIEF-SSY Obtains Nmpa Approval For Urapidil Sustained-Release Capsules & Nicardipine Hydrochloride & Sodium Chloride Injection

Reuters
·
Sep 01

SSY Group's Profit Falls in H1 on Lower Revenue; Shares Slide 3%

MT Newswires Live
·
Aug 28

Stock Track | SSY GROUP Plummets 5.41% Following Weak Interim Results with 58.7% Profit Decline

Stock Track
·
Aug 28

SSY GROUP (02005) Announces Interim Results with Profit Attributable to Shareholders of Approximately HK$283.5 Million, Down About 58.7% Year-on-Year

Stock News
·
Aug 28

SSY Group Ltd. Announces Interim Dividend of HKD 0.05 Per Share for First Half of 2025

Reuters
·
Aug 28

BRIEF-SSY Group Posts HY Revenue Of HK$2.15 Bln

Reuters
·
Aug 28

SSY Group - Hy Revenue HK$2.15 Bln

THOMSON REUTERS
·
Aug 28

SSY Group - Resolved to Pay an Interim Dividend of HK$0.05 per Share

THOMSON REUTERS
·
Aug 28

SSY Group H1 Gross Margin 41.5%

THOMSON REUTERS
·
Aug 28

SSY Group H1 Basic EPS HKD 283508000

THOMSON REUTERS
·
Aug 28

SSY Wins China Nod for Benidipine Hydrochloride Tablets

MT Newswires Live
·
Aug 25

SSY GROUP (02005): Receives Production Registration Certificate for Benidipine Hydrochloride Tablets

Stock News
·
Aug 25

SSY Group Ltd - Obtains China Nmpa Approval for Drug Production & Registration for Benidipine Hydrochloride Tablets

THOMSON REUTERS
·
Aug 25

BRIEF-SSY Group Says Morinidazole Approved By China's NMPA

Reuters
·
Aug 19

SSY Wins Approval for Morinidazole Bulk Drug in China

MT Newswires Live
·
Aug 19

SSY GROUP (02005): Morinidazole Receives NMPA Approval Registration as API for Marketed Formulations

Stock News
·
Aug 19

SSY Group - Morinidazole Approved by China's Nmpa

THOMSON REUTERS
·
Aug 19